These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria. Mohanty S, Gaind R, Ranjan R, Deb M. J Infect Dev Ctries; 2009 Nov 21; 4(1):24-9. PubMed ID: 20130375 [Abstract] [Full Text] [Related]
10. Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics. Jan IS, Hsueh PR, Teng LJ, Ho SW, Luh KT. J Formos Med Assoc; 1998 Oct 21; 97(10):661-6. PubMed ID: 9830274 [Abstract] [Full Text] [Related]
12. Molecular characteristics of extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae and the prevalence of qnr in Extended spectrum beta-lactamase isolates in a tertiary care hospital in Korea. Kim MH, Lee HJ, Park KS, Suh JT. Yonsei Med J; 2010 Sep 21; 51(5):768-74. PubMed ID: 20635454 [Abstract] [Full Text] [Related]
14. Evaluation of efficiency of screening extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent. Lee K, Lim JK, Yong D, Yum J, Chong Y, Okamoto R, Inoue M. J Clin Microbiol; 2001 Oct 21; 39(10):3696-9. PubMed ID: 11574594 [Abstract] [Full Text] [Related]
16. [Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae]. Wang QT, Liu YM, Wang H, Sun HL, Chen MJ, Du XL. Zhonghua Nei Ke Za Zhi; 2004 Jul 21; 43(7):487-90. PubMed ID: 15312399 [Abstract] [Full Text] [Related]